Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease

Journal of Periodontology

Volumn 80, Issue 9, 2009, Pages 1454-1461

  Pradeep, A R ^a   Daisy, Happy ^a   Hadge, Parag ^a   Garg, Garima ^a   Thorat, Manojkumar ^a  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Cytokines; Dental scaling; Gingival crevicular fluid; Periodontitis; Root planing

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; CCL2 PROTEIN, HUMAN; INTERLEUKIN 18; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ALVEOLAR BONE LOSS; ARTICLE; CHEMISTRY; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; FEMALE; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MOUTH HYGIENE; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PERIODONTIUM; PREVENTIVE DENTISTRY; TOOTH PLAQUE;

ADULT; AGED; ALVEOLAR BONE LOSS; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CHRONIC PERIODONTITIS; DENTAL PLAQUE; DENTAL SCALING; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVITIS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-18; MALE; MIDDLE AGED; ORAL HYGIENE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL DISEASES; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTIUM; ROOT PLANING;

EID: 69949150639     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.090117     Document Type: Article

References (41)

1. Genco RJ. Host responses in periodontal diseases: Current concepts. JPeriodontol 1992;63(Suppl. 4): 338-355.
2. Gemmell E, Marshall RI, Seymour GJ. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000 1997;14:112-143.
3. Nakamura K, Okamura H, Wada M, Nagata K, Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 1989;57: 590-595.
4. Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88-91.
5. Dinarello CA. IL-18: A TH1-inducing proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999;103:11-24.
6. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001;19:423-474.
7. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001;12: 53-72.
8. Johnson RB, Serio FG. Interleukin-18 concentrations and the pathogenesis of periodontal disease. J Periodontol 2005;76:785-790.
9. Miranda LA, Fischer RG, Sztajnbok FR, Johansson A, Figueredo CM, Gustafsson A. Increased interleukin-18 in patients with juvenile idiopathic arthritis and early attachment loss. J Periodontol 2005;76:75-82.
10. Orozco A, Gemmell E, Bickel M, Seymour GJ. Inter- leukin-1β, interleukin-12 and interleukin-18 levels in gingival crevicular fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol 2006;21:256-260.
11. Figueredo CM, Rescala B, Teles RP, et al. Increased interleukin-18 in gingival crevicular fluid from periodontitis patients. Oral Microbiol Immunol 2008;23: 173-176.
12. Premack BA, Schall TJ. Chemokine receptors: Gateways to inflammation and infection. Nat Med 1996; 2:1174-1178.
13. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992;12:17-46.
14. Valente AJ, Graves DT, Vialle-Valentin CE, Delgado R, Schwartz CJ. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 1988;27:4162-4168.
15. Jiang Y, Beller D, Frendl G, Graves D. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992;148:2423-2428.
16. Rollins BJ, Sunday ME. Suppression of tumor formation in vivo by expression of the IE gene in malignant cells. Mol Cell Biol 1991;11:3125-3131.
17. Daly C, Rollins BJ. Monocyte chemoattractant pro- tein-1 (CCL2) in inflammatory disease and adaptive immunity: Therapeutic opportunities and controversies. Microcirculation 2003;10:247-257.
18. Yu X, Antoniades H, Graves D. Expression of mono- cyte-chemoattractant protein-1 in human inflamed gingival tissues. Infect Immun 1993;61:4622-4628.
19. Tonetti MS, Imboden MA, Gerber L, Lang NP, Laissue J, Mueller C. Localized expression of mRNA for phagocytic- specific chemotactic cytokines in human periodontal infections. Infect Immun 1994;62:4005-4014.
20. Emingil G, Atilla G, Huseyinov A. Gingival crevicu- lar fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis. J Clin Periodontol 2004;31:829-834.
21. Kurtiş B, Tüter G, Serdar M, et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol 2005;76: 1849-1855.
22. Hanazawa S, Kawata Y, Takeshita A, et al. Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: Increased monocyte che- motactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun 1993;61:5219-5224.
23. Yoo JK, Kwon H, Khil LY, Zhang L, Jun HS, Yoon JW. IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylin- ositol 3-kinase/Akt and MEK/ERK1/2 pathways. J Immunol 2005;175:8280-8286.
24. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 21:533-551.
25. Quirynen M, De Soete M, Boschmans G, et al. Benefit of ''one-stage, full-mouth disinfection'' is explained by disinfection and root planing within 24 hours: A randomized controlled trial. J Clin Periodontol 2006; 33:639-647.
26. Jervøe-Storm P-M, Semaan E, AlAhdab H, Engel S, Fimmers R, Jepsen S. Clinical outcomes of quadrant root planing versus full-mouth root planing. J Clin Periodontol 2006;33:209-215.
27. Non-surgical periodontal treatment: Consensus statement. In: Nevins M, Becker W, Kornman K, eds. Proceedings ofthe World Workshop in Clinical Periodontics. Chicago: American Academy of Periodontology; 1989:II-13-II-20.
28. 28. Badersten A, Nilveus R, Egelberg J. Effect of nonsur- gical periodontal therapy. I. Moderately advanced periodontitis. J Clin Periodontol 1981;8:57-72.
29. Griffiths GS. Formation, collection and significance of gingival crevicular fluid. Periodontol 2000 2003;31: 32-42.
30. Jabloińska E, Izycka A, Wawrusiewicz N. Effect of IL-18 on IL-1 beta and sIL-1RII production by human neutrophils. Arch Immunol Ther Exp (Warsz) 2002; 50:139-141.
31. Tschoeke SK, Oberholzer A, Moldawer LL. Interleukin- 18: A novel prognostic cytokine in bacteria-induced sepsis. Crit Care Med 2006;34:1225-1233.
32. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994;91:3652-3656.
33. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B. Activation of NK cells by CC chemokines: Chemotaxis, Ca2+ mobilization, and enzyme release. J Immunol 1996;156:322-327.
34. Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ, Kaplan AP. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med 1992;175:489-493.
35. Garlet GP, Martins W Jr., Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 2003;38: 210-217.
36. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-242.
37. Baker PJ. The role of immune responses in bone loss during periodontal disease. Microbes Infect 2000;2: 1181-1192.
38. LeBlanc PA, Heath LS, Um HD. Activated macrophages use different cytolytic mechanisms to lyse a virally infected or a tumor target. J Leukoc Biol 1990;48:1-6.
39. Foster N, Cheetham J, Taylor JJ, Preshaw PM. VIP inhibits Porphyromonas gingivalis LPS-induced immune responses in human monocytes. J Dent Res 2005;84:999-1004.
40. Foster N, Lea SR, Preshaw PM, Taylor JJ. Pivotal advance: Vasoactive intestinal peptide inhibits up- regulation of human monocyte TLR2 and TLR4 by LPS and differentiation of monocytes to macrophages. J Leukoc Biol 2007;81:893-903.
41. Foster N, Andreadou K, Jamieson L, Preshaw PM, Taylor JJ. VIP inhibits P. gingivalis LPS-induced IL-18 and IL-18BPa in monocytes. J Dent Res 2007;86: 883-887.